Skip to main content

. 1958 Feb;21(1):55–57. doi: 10.1136/jnnp.21.1.55

A CONTROLLED TRIAL OF METHYL PHENIDATE (RITALIN) IN THE TREATMENT OF DEPRESSIVE STATES

A A Robin ¹, S Wiseberg ¹

PMCID: PMC497294 PMID: 13514499

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

DAVIES D. L., SHEPHERD M. Reserpine in the treatment of anxious and depressed patients. Lancet. 1955 Jul 16;269(6881):117–120. doi: 10.1016/s0140-6736(55)92118-8. [DOI] [PubMed] [Google Scholar]
FERGUSON J. T. Treatment of reserpine-induced depression with a new analeptic: phenidylate. Ann N Y Acad Sci. 1955 Apr 15;61(1):101–107. doi: 10.1111/j.1749-6632.1955.tb42456.x. [DOI] [PubMed] [Google Scholar]
GELLER W. Behandlung depressiver Verstimmungszustände mit einem neuen zentralen Stimulans. Medizinische. 1955 Apr 16;16:606–608. [PubMed] [Google Scholar]
HEISS R., BECKER H., HILTMANN H., HONSBERG I. Uber psychische Wirkungen eines neuartigen Psychotonikums. Medizinische. 1956 Feb 18;(7):260–262. [PubMed] [Google Scholar]
MEIER R., GROSS F., TRIPOD J. Ritalin, eine neuartige synthetische Verbindung mit spezifischer zentralerregender Wirkungskomponente. Klin Wochenschr. 1954 May 15;32(19-20):445–450. doi: 10.1007/BF01466968. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES